SCHEMBL2889730

SCHEMBL2889730

Nc1nc(F)nc(F)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6003429 0.84 AXL (0.30)
SCHEMBL5675318 0.77 MEN1 (0.33)
SCHEMBL6003760 0.67 REV1 (0.30)
SCHEMBL10797791 0.67
SCHEMBL7171640 0.67 LMNA (0.32)
SCHEMBL17156504 0.67 MEN1 (0.34)
SCHEMBL9162427 0.65 DCPS (0.35)
SCHEMBL1002200 0.65 MEN1 (0.36)
SCHEMBL10027671 0.65
SCHEMBL8581211 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118767991-A Catalyst, preparation method thereof and application of catalyst in cyclododecanone synthesis 万华化学集团股份有限公司 2024-10-15 CN claimed
CN-118767991-A Catalyst, preparation method thereof and application of catalyst in cyclododecanone synthesis 万华化学集团股份有限公司 2024-10-15 CN disclosed
EP-1973897-B1 Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders BAYER IP GMBH (DE) 2014-05-21 EP disclosed
US-8580798-B2 Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-11-12 US disclosed
US-20100081812-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2010-04-01 US disclosed
EP-1973897-A2 SUBSTITUTED PYRYMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS Bayer HealthCare AG (DE) 2008-10-01 EP disclosed
WO-2007075650-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER HEALTHCARE AG (DE) 2007-07-05 WO disclosed